Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-15 Sale |
2024-03-19 2:30 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
50,000 | $6 | $300,000 | 984,476 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-12 1:45 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
25,000 | $5.1874 | $129,685 | 1,034,476 (Direct) |
View |
| 2022-06-08 Purchase |
2022-06-10 5:26 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
45,871 | $0.96 | $44,036 | 928,742 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-10 8:17 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
35,000 | $6.75 | $236,250 | 837,000 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-09 4:00 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
40,792 | $6.5 | $265,148 | 872,000 (Direct) |
View |
| 2020-05-08 Sale |
2020-05-11 4:15 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
40,000 | $5 | $200,000 | 902,113 (Direct) |
View |
| 2020-04-29 Sale |
2020-05-01 4:05 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
40,000 | $4.5 | $180,000 | 1,022,113 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-09 Tax Withholding(A) |
2024-10-02 2:16 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
9,645 | $4.88 | 980,726 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:45 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
5,895 | $4.88 | 1,034,476 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:36 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
123,750 | $0 | 1,106,621 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 4:30 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-05 4:00 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-09 3:07 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
100,000 | $0 | 982,871 (Direct) |
View |
| 2022-11-04 Option Award |
2022-11-08 10:22 am |
N/A 2032-11-04 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:25 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:00 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
94 | $4.86 | 912,792 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:00 pm |
2020-06-30 N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
333 | $0 | 912,792 (Direct) |
View |
| 2020-05-31 Tax Withholding |
2020-06-02 5:14 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
4,132 | $4.87 | 912,553 (Direct) |
View |
| 2020-05-31 Exercise |
2020-06-02 5:14 pm |
2020-05-31 N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
14,572 | $0 | 912,553 (Direct) |
View |